Evidence map›Paper›PMID 33765229›Full record

ArticleMetabolic brain disease2021

Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin.

Dalia O Saleh, Dina F Mansour, Ahmed M Fayez

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dalia O SalehDepartment of Pharmacology, National Research Centre (ID: 60014618), 33 El Buhouth st-Dokki, Cairo, P.O:12622, Egypt. doabdelfattah@yahoo.com.ORCID http://orcid.org/0000-0002-5401-5422
Dina F MansourDepartment of Pharmacology, National Research Centre (ID: 60014618), 33 El Buhouth st-Dokki, Cairo, P.O:12622, Egypt.
Ahmed M FayezDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Science and Arts (MSA University), 6th of October, Egypt.
National Research Centre · EGOctober University of Modern Sciences and Arts · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic encephalopathy (HE) is a debilitating and life-threatening disease. Results from acute or chronic liver failure and is characterized by abnormal cerebral and neurological alterations. This study aimed at investigating the effect of allicin, the major functional component in freshly crushed garlic extract, on thioacetamide (TAA)-induced HE in rats. Induction of HE by a single dose of TAA (300 mg/kg; I.P.) was associated with a marked elevation in the serum levels of alanine aminotransferase, aspartate aminotransferase, bilirubin, albumin, total protein, blood urea nitrogen and serum ammonia besides reduction in the serum level of albumin. Moreover, it was accompanied with an increase in the hepatic and brain levels of inflammatory mediators; TNF-α and IL-1β as well as elevation of the hepatic and brain levels of oxidative stress biomarkers; reduced glutathione and lipid peroxidation evidenced by malondialdeyde. Oral administration of allicin (50, 100 and 200 mg/kg; P.O.) for 6 days prior to TAA injection restored the serum liver function, hepatic and brain levels of inflammatory mediators as well as oxidative stress biomarkers in a dose-dependent manner. From our results, it can be concluded that allicin has a protective effect on TAA-induced HE in rats in a dose-dependent manner due to its powerful antioxidant and anti-inflammatory properties.

Indexed as

ThioacetamideAnimalsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsBrain ChemistryCentral Nervous SystemCytokinesDisulfidesDose-Response Relationship, DrugHepatic EncephalopathyLiver Function TestsMaleNeuroprotective AgentsOxidative StressPeripheral Nervous SystemRatsallicinAnti-Inflammatory Agents, Non-SteroidalAntioxidantsCytokinesDisulfidesNeuroprotective AgentsSulfinic AcidsThioacetamideAllicinAnti-inflammatoryAntioxidantHepatic encephalopathyLiver failure

Identifiers

PMID33765229
OpenAlexW3135957846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.